<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>00382903833382</udiDi>
    <basicUdiDi>038290ESLWZLJRKH</basicUdiDi>
    <tradeName>Saf-T-Intima</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Becton Dickinson Infusion Therapy Systems Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017719</manufacturerSrn>
    <authorisedRepresentativeName>Becton Dickinson Ireland Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000007610</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>383338</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-07T05:18:07.339Z</lastUpdated>
  </row>
  <row>
    <udiDi>00382903833399</udiDi>
    <basicUdiDi>038290ESLWZLJRKH</basicUdiDi>
    <tradeName>Saf-T-Intima</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Becton Dickinson Infusion Therapy Systems Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017719</manufacturerSrn>
    <authorisedRepresentativeName>Becton Dickinson Ireland Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000007610</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>383339</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-07T05:18:07.319Z</lastUpdated>
  </row>
  <row>
    <udiDi>00382903833481</udiDi>
    <basicUdiDi>038290ESLWZLJRKH</basicUdiDi>
    <tradeName>Saf-T-Intima</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Becton Dickinson Infusion Therapy Systems Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017719</manufacturerSrn>
    <authorisedRepresentativeName>Becton Dickinson Ireland Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000007610</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>383348</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-07T05:18:07.273Z</lastUpdated>
  </row>
  <row>
    <udiDi>00382903836918</udiDi>
    <basicUdiDi>038290KJKZSYMBJP</basicUdiDi>
    <tradeName>Nexiva</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Becton Dickinson Infusion Therapy Systems Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017719</manufacturerSrn>
    <authorisedRepresentativeName>Becton Dickinson Ireland Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000007610</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>PERIPHERAL I.V. CATHETERS, WITH INTEGRATED EXTENSIONS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>383691</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-07T05:18:07.031Z</lastUpdated>
  </row>
  <row>
    <udiDi>00382903836925</udiDi>
    <basicUdiDi>038290KJKZSYMBJP</basicUdiDi>
    <tradeName>Nexiva</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Becton Dickinson Infusion Therapy Systems Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017719</manufacturerSrn>
    <authorisedRepresentativeName>Becton Dickinson Ireland Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000007610</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>PERIPHERAL I.V. CATHETERS, WITH INTEGRATED EXTENSIONS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>383692</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-07T05:18:06.992Z</lastUpdated>
  </row>
  <row>
    <udiDi>00382903836932</udiDi>
    <basicUdiDi>038290KJKZSYMBJP</basicUdiDi>
    <tradeName>Nexiva</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Becton Dickinson Infusion Therapy Systems Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017719</manufacturerSrn>
    <authorisedRepresentativeName>Becton Dickinson Ireland Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000007610</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>PERIPHERAL I.V. CATHETERS, WITH INTEGRATED EXTENSIONS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>383693</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-07T05:18:06.964Z</lastUpdated>
  </row>
  <row>
    <udiDi>00382903836949</udiDi>
    <basicUdiDi>038290KJKZSYMBJP</basicUdiDi>
    <tradeName>Nexiva</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Becton Dickinson Infusion Therapy Systems Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017719</manufacturerSrn>
    <authorisedRepresentativeName>Becton Dickinson Ireland Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000007610</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>PERIPHERAL I.V. CATHETERS, WITH INTEGRATED EXTENSIONS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>383694</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-07T05:18:06.936Z</lastUpdated>
  </row>
  <row>
    <udiDi>00382903836956</udiDi>
    <basicUdiDi>038290KJKZSYMBJP</basicUdiDi>
    <tradeName>Nexiva</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Becton Dickinson Infusion Therapy Systems Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017719</manufacturerSrn>
    <authorisedRepresentativeName>Becton Dickinson Ireland Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000007610</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>PERIPHERAL I.V. CATHETERS, WITH INTEGRATED EXTENSIONS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>383695</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-07T05:18:06.900Z</lastUpdated>
  </row>
  <row>
    <udiDi>00382903913794</udiDi>
    <basicUdiDi>038290ZCNOSRXLMV</basicUdiDi>
    <tradeName>NEOFLON</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Becton Dickinson Infusion Therapy Systems Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017719</manufacturerSrn>
    <authorisedRepresentativeName>Becton Dickinson Ireland Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000007610</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>391379</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-07T05:18:06.766Z</lastUpdated>
  </row>
  <row>
    <udiDi>00382903913800</udiDi>
    <basicUdiDi>038290ZCNOSRXLMV</basicUdiDi>
    <tradeName>NEOFLON</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Becton Dickinson Infusion Therapy Systems Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017719</manufacturerSrn>
    <authorisedRepresentativeName>Becton Dickinson Ireland Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000007610</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>391380</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-07T05:18:06.748Z</lastUpdated>
  </row>
  <row>
    <udiDi>00382903932023</udiDi>
    <basicUdiDi>038290CPXPNDXWGX</basicUdiDi>
    <tradeName>Venflon</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Becton Dickinson Infusion Therapy Systems Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017719</manufacturerSrn>
    <authorisedRepresentativeName>Becton Dickinson Ireland Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000007610</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>393202</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-07T05:18:06.691Z</lastUpdated>
  </row>
  <row>
    <udiDi>00382903932047</udiDi>
    <basicUdiDi>038290CPXPNDXWGX</basicUdiDi>
    <tradeName>Venflon</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Becton Dickinson Infusion Therapy Systems Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017719</manufacturerSrn>
    <authorisedRepresentativeName>Becton Dickinson Ireland Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000007610</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>393204</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-07T05:18:06.665Z</lastUpdated>
  </row>
  <row>
    <udiDi>00382903932061</udiDi>
    <basicUdiDi>038290CPXPNDXWGX</basicUdiDi>
    <tradeName>Venflon</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Becton Dickinson Infusion Therapy Systems Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017719</manufacturerSrn>
    <authorisedRepresentativeName>Becton Dickinson Ireland Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000007610</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>393206</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-07T05:18:06.643Z</lastUpdated>
  </row>
  <row>
    <udiDi>00382903932078</udiDi>
    <basicUdiDi>038290CPXPNDXWGX</basicUdiDi>
    <tradeName>Venflon</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Becton Dickinson Infusion Therapy Systems Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017719</manufacturerSrn>
    <authorisedRepresentativeName>Becton Dickinson Ireland Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000007610</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>393207</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-07T05:18:06.620Z</lastUpdated>
  </row>
  <row>
    <udiDi>00382903932085</udiDi>
    <basicUdiDi>038290CPXPNDXWGX</basicUdiDi>
    <tradeName>Venflon</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Becton Dickinson Infusion Therapy Systems Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017719</manufacturerSrn>
    <authorisedRepresentativeName>Becton Dickinson Ireland Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000007610</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>393208</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-07T05:18:06.598Z</lastUpdated>
  </row>
  <row>
    <udiDi>00382903932092</udiDi>
    <basicUdiDi>038290CPXPNDXWGX</basicUdiDi>
    <tradeName>Venflon</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Becton Dickinson Infusion Therapy Systems Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017719</manufacturerSrn>
    <authorisedRepresentativeName>Becton Dickinson Ireland Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000007610</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>393209</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-07T05:18:06.569Z</lastUpdated>
  </row>
  <row>
    <udiDi>00382903932108</udiDi>
    <basicUdiDi>038290CPXPNDXWGX</basicUdiDi>
    <tradeName>Venflon</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Becton Dickinson Infusion Therapy Systems Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017719</manufacturerSrn>
    <authorisedRepresentativeName>Becton Dickinson Ireland Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000007610</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>393210</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-07T05:18:06.545Z</lastUpdated>
  </row>
  <row>
    <udiDi>00382903932535</udiDi>
    <basicUdiDi>038290CRHGWSVQC6</basicUdiDi>
    <tradeName>Venflon</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Becton Dickinson Infusion Therapy Systems Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017719</manufacturerSrn>
    <authorisedRepresentativeName>Becton Dickinson Ireland Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000007610</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>393253</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-07T05:18:06.475Z</lastUpdated>
  </row>
  <row>
    <udiDi>00382903932559</udiDi>
    <basicUdiDi>038290CRHGWSVQC6</basicUdiDi>
    <tradeName>Venflon</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Becton Dickinson Infusion Therapy Systems Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017719</manufacturerSrn>
    <authorisedRepresentativeName>Becton Dickinson Ireland Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000007610</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>393255</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-07T05:18:06.450Z</lastUpdated>
  </row>
  <row>
    <udiDi>00382903932573</udiDi>
    <basicUdiDi>038290CRHGWSVQC6</basicUdiDi>
    <tradeName>Venflon</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Becton Dickinson Infusion Therapy Systems Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017719</manufacturerSrn>
    <authorisedRepresentativeName>Becton Dickinson Ireland Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000007610</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>393257</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-07T05:18:06.423Z</lastUpdated>
  </row>
</eudamedExport>